Inventor · disambiguated record
Seong-Ho Koh
Also filed as: KOH SEONG-HO
17 granted patents·10 pending applications·58 citations·filing 2006–2024
93Inventor score
Files withGEMVAX & KAEL CO LTD16KIM SANG JAE5SEOUL NAT UNIV R&DB FOUNDATION4KIM HEE-TAE1KOH SEONG HO1
Top patents by PatentIndex Score
27 records- 0198US11369665B2Anti-inflammatory peptides and composition comprising the sameGEMVAX & KAEL CO LTD·Filed 2020·Granted Jun 28, 2022·4 cites·9 claims
- 0295US10960056B2Anti-inflammatory peptides and composition comprising the sameGEMVAX & KAEL CO LTD·Filed 2018·Granted Mar 30, 2021·4 cites·9 claims
- 0395US10039811B2Anti-inflammatory peptides and composition comprising the sameGEMVAX & KAEL CO LTD·Filed 2016·Granted Aug 7, 2018·10 cites·9 claims
- 0495US9540419B2Anti-inflammatory peptides and composition comprising the sameGEMVAX & KAEL CO LTD·Filed 2013·Granted Jan 10, 2017·20 cites·8 claims
- 0593US9527888B2Anti-inflammatory peptides and composition comprising the sameGEMVAX & KAEL CO LTD·Filed 2013·Granted Dec 27, 2016·11 cites·3 claims
- 0692US10888606B2Anti-inflammatory peptides and compositions comprising the sameGEMVAX & KAEL CO LTD·Filed 2018·Granted Jan 12, 2021·2 cites·3 claims
- 0791US12168039B2Anti-inflammatory peptides and composition comprising the sameGEMVAX & KAEL CO LTD·Filed 2023·Granted Dec 17, 2024·0 cites·8 claims
- 0891US12156902B2Anti-inflammatory peptides and composition comprising the sameGEMVAX & KAEL CO LTD·Filed 2023·Granted Dec 3, 2024·0 cites·8 claims
- 0990US11622998B2Anti-inflammatory peptides and composition comprising the sameGEMVAX & KAEL CO LTD·Filed 2020·Granted Apr 11, 2023·1 cites·7 claims
- 1089US12171812B2Anti-inflammatory peptides and composition comprising the sameGEMVAX & KAEL CO LTD·Filed 2023·Granted Dec 24, 2024·0 cites·4 claims
- 1187US10206981B2Anti-inflammatory peptides and composition comprising the sameGEMVAX & KAEL CO LTD·Filed 2016·Granted Feb 19, 2019·3 cites·12 claims
- 1285US11857607B2Anti-inflammatory peptides and composition comprising the sameGEMVAX & KAEL CO LTD·Filed 2022·Granted Jan 2, 2024·0 cites·8 claims
- 1385US2024158768A1Anti-inflammatory peptides and composition comprising the sameKIM SANG JAE·Filed 2024·Application pending·0 cites
- 1483US11098294B2Anti-inflammatory peptides and composition comprising sameGEMVAX & KAEL CO LTD·Filed 2020·Granted Aug 24, 2021·1 cites·5 claims
- 1578US11905536B2Anti-inflammatory peptides and composition comprising the sameGEMVAX & KAEL CO LTD·Filed 2021·Granted Feb 20, 2024·0 cites·6 claims
- 1667US2020140832A1Anti-inflammatory peptides and composition comprising the sameKIM SANG JAE·Filed 2020·Application pending·0 cites
- 1765US8951511B2Compositions for improving migration potential of stem cellsKOH SEONG HO·Filed 2010·Granted Feb 10, 2015·2 cites·4 claims
- 1862US2025041350A1Pharmaceutical composition for prevention or treatment of vascular dementiaSEOUL NAT UNIV R&DB FOUNDATION·Filed 2023·Application pending·0 cites
- 1959US2017275603A1Anti-Inflammatory Peptides and Composition Comprising the SameKIM SANG JAE·Filed 2017·Application pending·0 cites
- 2058US2015125438A1Anti-Inflammatory Peptides and Composition Comprising the SameKIM SANG JAE·Filed 2013·Application pending·0 cites
- 2157US2025186504A1Pharmaceutical composition for alleviation or treatment of cerebral infarction sequelaSEOUL NAT UNIV R&DB FOUNDATION·Filed 2023·Application pending·0 cites
- 2253US2017327802A1Anti-Inflammatory Peptides and Composition Comprising the SameKIM SANG JAE·Filed 2017·Application pending·0 cites
- 2351US8277795B2Methods and compositions for treating motor neuron diseases comprising mesenchymal stem cellsKIM HEE TAE·Filed 2006·Granted Oct 2, 2012·0 cites·4 claims
- 2443US2022339198A1Pharmaceutical composition for alzheimer's treatment containing as active ingredient late passage human mesenchymal stem cells induced to differentiate into glia-like cellsSEOUL NAT UNIV R&DB FOUNDATION·Filed 2020·Application pending·0 cites
- 2543US2022331368A1Pharmaceutical composition comprising glia-like cells induced from late-passage human mesenchymal stem cells as active ingredient for treatment of strokeSEOUL NAT UNIV R&DB FOUNDATION·Filed 2020·Application pending·0 cites
- 2641US10898540B2Peptide having effects of increasing telomerase activity and extending telomere, and composition containing sameGEMVAX & KAEL CO LTD·Filed 2017·Granted Jan 26, 2021·0 cites·6 claims
- 2735US2018318383A1Peptide having neuronal loss prevention and regeneration effects, and composition containing sameGEMVAX & KAEL CO LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Seong-Ho Koh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →